Concepedia

INTRAVESICAL CHEMOTHERAPY AND IMMUNOTHERAPY: HOW DO WE ASSESS THEIR EFFECTIVENESS AND WHAT ARE THEIR LIMITATIONS AND USES?

Lamm Dl, APM van de Meijden, Hideyuki Akaza, ChB Brendler, Hedlund Po, Yoichi Mizutani, T. L. Ratliff, MRG Robinson, T. Shinka

International Journal of Urology · 1995 · 64 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Superficial Bladder Cancer: Progression and Recurrence

Niall M. Heney, Susan Ahmed, Malachi J. Flanagan et al. · The Journal of Urology · 1983 · 945 citations

, , +16

Non-Invasive Papillary Carcinoma of the Bladder Associated with Carcinoma in Situ

Alex F. Althausen, George R. Prout, James Daly · The Journal of Urology · 1976 · 451 citations

, , +12

A Prospective European Organization for Research and Treatment of Cancer Genitourinary Group Randomized Trial Comparing Transurethral Resection Followed by a Single Intravesical Instillation of Epirubicin or Water in Single Stage Ta, T1 Papillary Carcinoma of the Bladder

Willem Oosterlinck, Karl H. Kurth, Fritz H. Schröder et al. · The Journal of Urology · 1993 · 367 citations

, , +12

Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer

Donald L. Lamm · The Journal of Urology · 1985 · 302 citations

, , +9

Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.

H.W. Herr, Vincent P. Laudone, Robert A. Badalament et al. · Journal of Clinical Oncology · 1988 · 287 citations

, , +13